AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Jernstrom, H Chu, M Vesprini, D Tao, YZ Majeed, N Deal, C Pollak, M Narod, SA
Citation: H. Jernstrom et al., Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: Implications for premenopausal breast cancer risk, MOL GEN MET, 72(2), 2001, pp. 144-154

Authors: Jernstrom, H Deal, C Wilkin, F Chu, W Tao, YZ Majeed, N Hudson, T Narod, SA Pollak, M
Citation: H. Jernstrom et al., Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women, CANC EPID B, 10(4), 2001, pp. 377-384

Authors: Lufkin, EG Wong, M Deal, C
Citation: Eg. Lufkin et al., The role of selective estrogen receptor modulators in the prevention and treatment of osteoporosis, RHEUM DIS C, 27(1), 2001, pp. 163

Authors: Mircescu, H Wilkin, F Paquette, J Oligny, LL Decaluwe, H Gaboury, L Nolet, S Van Vliet, G Deal, C
Citation: H. Mircescu et al., Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease, J PEDIAT, 138(2), 2001, pp. 269-273

Authors: Deal, C Ma, J Wilkin, F Paquette, J Rozen, F Ge, B Hudson, T Stampfer, M Pollak, M
Citation: C. Deal et al., Novel promoter polymorphism in insulin-like growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators, J CLIN END, 86(3), 2001, pp. 1274-1280

Authors: Deal, C
Citation: C. Deal, Can calcium and vitamin D supplementation adequately treat most patients with osteoporosis?, CLEV CLIN J, 67(10), 2000, pp. 696

Authors: Mircescu, H Parma, J Huot, C Deal, C Oligny, LL Vassart, G Van Vliet, G
Citation: H. Mircescu et al., Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: Pathologic and molecular studies, J PEDIAT, 137(4), 2000, pp. 585-587

Authors: Wilkin, F Gagne, N Paquette, J Oligny, LL Deal, C
Citation: F. Wilkin et al., Pediatric adrenocortical tumors: Molecular events leading to insulin-like growth factor II gene overexpression, J CLIN END, 85(5), 2000, pp. 2048-2056

Authors: Ward, L Huot, C Lambert, R Deal, C Collu, R Van Vliet, G
Citation: L. Ward et al., Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine, CLIN INV M, 22(4), 1999, pp. 132-139

Authors: Ward, L Paquette, J Seidman, E Huot, C Alvarez, F Crock, P Delvin, E Kampe, O Deal, C
Citation: L. Ward et al., Severe autoimmune polyendocrinopathy candidiasis ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressivetherapy, J CLIN END, 84(3), 1999, pp. 844-852

Authors: Hans, M Urrutia, A Deal, C Brust, PF Stauderman, K Ellis, SB Harpold, MM Johnson, EC Williams, ME
Citation: M. Hans et al., Structural elements in domain IV that influence biophysical and pharmacological properties of human alpha(1A)-containing high-voltage-activated calcium channels, BIOPHYS J, 76(3), 1999, pp. 1384-1400

Authors: Kiess, W Paquette, J Koepf, G Wolf, E Deal, C
Citation: W. Kiess et al., Proinsulin-like growth factor-II overexpression does not alter monoallelicH19 gene expression in transfected human embryonic kidney fibroblasts, BIOC BIOP R, 255(2), 1999, pp. 226-230

Authors: Felson, DT LaValley, MP Baldassare, AR Block, JA Caldwell, JR Cannon, GW Deal, C Evans, S Fleischmann, R Gendreau, RM Harris, ER Matteson, EL Roth, SH Schumacher, HR Weisman, MH Furst, DE
Citation: Dt. Felson et al., The Prosorba column for treatment of refractory rheumatoid arthritis - A randomized, double-blind, sham-controlled trial, ARTH RHEUM, 42(10), 1999, pp. 2153-2159

Authors: Van Vliet, G Deal, C
Citation: G. Van Vliet et C. Deal, Growth hormone supplementation in Turner's syndrome, J PEDIAT, 133(6), 1998, pp. 803-803
Risultati: 1-14 |